Skip to content

Hemodynamics After Resistance Training

Investigating Resistance Training for Vascular Function and Quality of Life in Perimenopausal Women

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07022340
Acronym
HeART
Enrollment
50
Registered
2025-06-15
Start date
2025-06-06
Completion date
2026-12-01
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Perimenopause

Keywords

menopause, perimenopause, vascular function, arterial stiffness, endothelial function, resistance exercise training, strength training, mood, sleep, quality of life, cardiovascular disease, estrogen deficiency, exercise

Brief summary

Women's blood vessel health gets worse after menopause, or "the change of life". Some women exercise less during menopause. Exercise can improve blood vessel health. The investigators want to know if resistance exercise, like lifting weights, can improve blood vessel health in women who are just starting menopause. The investigators also want to know if lifting weights can improve mood, sleep, and quality of life in women going through menopause. The investigators will have two groups of women for this study. One group will lift weights (do resistance exercise) twice per week, and the other group will get emails with information about menopause. The investigators will measure blood vessel health, sleep, mood, and menopause symptoms at the start and the end of this study and compare women who did and did not exercise.

Detailed description

Perimenopause is an important time when heart disease risk increases. Perimenopause is also related to worse health-related quality of life, sleep disruptions, and mood. Poor sleep and mood are both related to cardiovascular disease risk. Resistance exercise is effective at reducing cardiovascular disease risk in premenopausal women, and also improves mood, menopausal symptoms, and sleep quality in post-menopausal women. Resistance exercise does not consistently improve vascular function, such as arterial stiffness and blood vessel reactivity, in post-menopausal women. This study aims to investigate the effect of resistance training intervention on vascular function in perimenopausal women. This study will also determine if resistance training improves other novel cardiovascular disease risk factors that tend to worsen in perimenopause, such as sleep quality, mood, and menopause-specific quality of life. The investigators will conduct a randomized controlled trial in perimenopausal females. Participants will complete baseline vascular function and exercise testing at baseline. Blood and urine will be collected. Participants will also complete surveys about their sleep, mood, and menopause-specific quality of life. Participants will be randomized to resistance training or control group. Those randomized to resistance training will complete two sessions per week for 16 weeks. The control group will receive a weekly health education email. Following the 16-week intervention or control, participants will complete post-intervention vascular function and exercise testing, and the same surveys as at baseline. Comparisons will be made between the exercise and control groups.

Interventions

Participants will complete a brief aerobic warm-up and dynamic stretching prior to each strength training session. Participants will complete 9 exercises for all major muscle groups. Strength testing at the baseline study visit will be used to determine initial load. Participants will complete 1 set of moderate-intensity loads (\~50% maximum and \~12 repetitions) in week 1, 2 sets in week 2, and 3 sets in week 3. By week 4, participants will be completing 3 sets at 60% of maximum. Weight loads will be progressively increased so volitional fatigue is reached by 8-12 repetitions/set.

Sponsors

University of Michigan
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
40 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

* Are between 40-60 years old * Have had menstrual irregularities in the last 12 months * Do not currently complete more than two 30-min sessions of structured exercise per week and do not do any resistance training exercise; * Are not currently pregnant * Do not smoke or vape nicotine or marijuana * Have not had an oophorectomy, hysterectomy, or surgical menopause * Are not currently taking hormone replacement therapy * Have not taken hormone replacement therapy in the last 6 months * Are not taking steroidal medication or medication to treat diabetes, cholesterol, or high blood pressure * Are able to exercise - your doctor has not told you that you cannot exercise * Can attend a morning study visit at the University of Michigan's School of Kinesiology Building * Are willing to avoid food 2 hours prior to the morning study visit * Are willing to avoid strenuous exercise, caffeine, and alcohol, 8 hours prior to the morning study visit * Are willing to participate in an exercise training program or health education program for 16 weeks

Design outcomes

Primary

MeasureTime frameDescription
Vascular functionAt baseline and the end of the 16 week study periodArterial stiffness and wave reflection will be measured at baseline and following the 16-week study period using cuff-based waveform acquisition and applanation tonometry.
Endothelial FunctionAt baseline and the end of the 16 week study periodEndothelial function will be measured at baseline and following the 16-week study period using brachial artery flow-mediated dilation measured with vascular ultrasound.

Secondary

MeasureTime frameDescription
Mood scoresAt baseline and the end of the 16 week study periodMood will be assessed using validated surveys (PROMIS) at baseline and following the 16-week study period.
Sleep qualityAt baseline and the end of the 16 week study periodSleep quality will be assessed using a validated survey (PSQI) at baseline and following the 16-week study period.
Menopause-specific quality of lifeAt baseline and the end of the 16 week study periodMenopause-specific quality of life will be assessed using a validated survey (MENQOL) at baseline and following the 16-week study period

Countries

United States

Contacts

CONTACTMarnie K. McLean, M.S.
mcmarnie@umich.edu734-615-1711
CONTACTAbbi D. Lane, Ph.D.
abbilane@umich.edu734-647-3843
PRINCIPAL_INVESTIGATORMarnie K. McLean, M.S.

University of Michigan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 4, 2026